AKUMS DRUGS & PHARMACEUTICALS LTD. share price has plunged 4% and is presently trading at Rs 854.0.
Meanwhile, the BSE HEALTHCARE index is at 42,350.2 (up 0.4%).
Among the top losers in the BSE HEALTHCARE index today are SYNGENE INTERNATIONAL (down 2.9%) and GRANULES INDIA (down 2.2%).
Jubilant Pharmova (up 3.6%) and CAPLIN POINT (up 3.6%) are among the top gainers today.
Over the last one year, AKUMS DRUGS & PHARMACEUTICALS LTD. has moved up from Rs 0.0 to Rs 854.0, registering a gain of Rs 854.0 .
On the other hand, the BSE HEALTHCARE index has moved up from 28,099.5 to 42,350.2, registering a gain of 50.7% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 126.8%), Glenmark Pharma (up 125.4%) and SUVEN PHARMACEUTICALS (up 104.2%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 81,841.8 (up 0.2%).
The top gainers among the BSE Sensex today are Maruti Suzuki (up 2.1%) and L&T (up 1.9%). The most traded stocks in the BSE Sensex are ICICI Bank and Tata Steel.
In the meantime, NSE Nifty is at 25,040.5 (up 0.1%). Shriram Transport and SBI LIFE INSURANCE are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,433.3 to 81,841.8, registering a gain of 16,408.5 points (up 25.1%).
AKUMS DRUGS & PHARMACEUTICALS LTD. net profit fell {profitpercent} YoY to Rs 612 million for the quarter ended June 2024, compared to a profit of Rs {profitnumberprev} million a year ago. Net sales declined {salespercent} to Rs 10,191 million during the period as against Rs {salesnumberprev} million in {quarterprev}.
For the year ended March 2024, AKUMS DRUGS & PHARMACEUTICALS LTD. reported 99.2% decrease in net profit to Rs 8 million compared to net profit of Rs 978 million during FY23. Revenue of the company grew 14.3% to Rs 41,782 million during FY24.
Equitymaster requests your view! Post a comment on "AKUMS DRUGS & PHARMACEUTICALS LTD. Plunges 4%; BSE HEALTHCARE Index Up 0.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!